Wed, 4 Nov
Vijaya Diagnostic Centre
Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
Summary ready
Earnings calls
Vijaya Diagnostic Centre concalls
Every Vijaya Diagnostic Centre earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
Outlook
Management raised revenue guidance to at least 20% for FY27, citing strong H1 momentum and network ramp-up.
Earlier call summaries
All →
11:27 IST
BSE
Earnings Call
Vijaya Diagnostic Centre Earnings Call: Key Takeaways
Vijaya Diagnostic reported a landmark FY26 with revenues crossing ₹800cr and Q4 revenue growth of 26.6%. The company is focusing on network expansion and high-end diagnostics like Genomics.
20:10 IST
NSE
Earnings Call
Vijaya Diagnostic Centre Earnings Call: Key Takeaways
Vijaya Diagnostic reported record FY26 revenue crossing ₹8,000 Mn with 41.4% EBITDA margins. Strategy focuses on deepening presence in South India and scaling West Bengal/Pune hubs.
20:07 IST
BSE
Earnings Call
Vijaya Diagnostic Centre Earnings Call: Key Takeaways
Vijaya Diagnostic reported record Q4 FY26 revenue of ₹2,194 Mn (up 26.6% YoY) and FY26 revenue of ₹8,142 Mn, driven by pathology and radiology momentum.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,425.00
- Market cap
- ₹14,677 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 72.1×Sector 53.8×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.